Shopping Cart
- Remove All
Your shopping cart is currently empty
HG-7-86-01 is a potent and selective type II tyrosine kinase inhibitor with antiproliferative activity against mutant T315I- Bcr-Abl for the treatment of chronic myeloid leukemia (CML).

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $68 | In Stock | |
| 5 mg | $168 | In Stock | |
| 10 mg | $268 | In Stock | |
| 25 mg | $538 | In Stock | |
| 50 mg | $766 | In Stock | |
| 100 mg | $987 | In Stock |
| Description | HG-7-86-01 is a potent and selective type II tyrosine kinase inhibitor with antiproliferative activity against mutant T315I- Bcr-Abl for the treatment of chronic myeloid leukemia (CML). |
| In vitro | HG-7-86-01 exhibits antiproliferative activity across multiple cell lines harboring mutant FLT3: Ba/F3-FLT3-ITD: IC₅₀ = 125–250 nM Ba/F3-Y572C: IC₅₀ = 12.5–25 nM Ba/F3-N841I: IC₅₀ = 200–400 nM Ba/F3-D835Y: IC₅₀ = 500–1000 nM [1] |
| Molecular Weight | 562.57 |
| Formula | C28H21F3N6O2S |
| Cas No. | 1258391-14-8 |
| Smiles | O=C(NC=1C=C(C=C(C1)C(F)(F)F)N2C=NC(=C2)C)C3=CC=CC(=C3)C4=NC=5SC(=NC5C=C4)NC(=O)C6CC6 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||
| Solubility Information | DMSO: 2 mg/mL (3.56 mM), Sonication is recommended. | ||||||||||
Solution Preparation Table | |||||||||||
DMSO
| |||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.